Trial NCT02720484

View at ClinicalTrials.gov 
Org. Study IDs: NU 15E01
Secondary IDs: NCI-2016-00194 NU 15E01 P30CA060553 STU00202153

Last trial update was posted on 2019-05-01

MeSH Interventions

Nivolumab

MeSH Conditions

Adrenocortical Carcinoma Carcinoma

Other Conditions

Metastatic Carcinoma in the Adrenal Cortex Recurrent Adrenal Cortex Carcinoma Stage III Adrenal Cortex Carcinoma Stage IV Adrenal Cortex Carcinoma

Stopping Reasons

Study did not meet first stage requirements of interim analysis

Limitations And Caveats

The study did not meet its first stage requirements of Interim analysis.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID